26 results on '"Pauer, L."'
Search Results
2. Disambiguating pharmacological mechanisms from placebo in neuropathic pain using functional neuroimaging
3. (413) Pregabalin and efficacy for pain score reduction in patients with fibromyalgia evaluated with and without potentially confounding effects
4. (411) Pregabalin dose-response in fibromyalgia and diabetic peripheral neuropathy
5. (403) Pregabalin for the treatment of fibromyalgia or painful diabetic peripheral neuropathy: analysis of crossover design studies
6. (404) Use of a placebo run-in in clinical trials in patients with FM does not impact the response to pregabalin
7. Challenges In Meeting Evidence Needs Of Payer, Physician, Patient And Industry Stakeholders For Novel Therapeutics
8. (396) Pregabalin is effective irrespective of antidepressant class in fibromyalgia patients currently receiving antidepressant medication for comorbid depression
9. (395) Pregabalin improves fibromyalgia symptoms in patients with fibromyalgia and comorbid depression receiving antidepressant medication: results from a randomized, 2-way crossover, double-blind, placebo-controlled study
10. Defining the Patient Journey via Claims Analysis in an Orphan Ophthalmic Condition: Is There a Standard of Care?
11. PAYER PERSPECTIVES ON DRUG PRICING, COVERAGE, AND REIMBURSEMENT IN OPHTHALMOLOGIC ORPHAN CONDITION IN THE UNITED STATES
12. The impact of prior opioid use on the response to pregabalin in fibromyalgia clinical trials
13. Effects of pregabalin on visual activation of the insular cortex in patients with fibromyalgia: an fMRI study
14. Pregabalin reduces insula grey matter density in fibromyalgia (FM)
15. Pregabalin alters default mode network activity in fibromyalgia
16. Examining the structure of the fibromyalgia impact questionnaire
17. Fibromyalgia patients: similar pattern of baseline diagnosis characteristics across regions
18. Pregabalin treatment improves fatigue, function and self-reported presenteeism in fibromyalgia (FM)
19. Relationships between Patient Global Impression of Change (PGIC) and other efficacy assessments in pregabalin fibromyalgia trials
20. Long-term safety and tolerability of pregabalin treatment in three open-label extension studies in patients with fibromyalgia
21. P.8.a.022 Do European patients with fibromyalgia respond differently than others to pregabalin? A 14-week monotherapy trial
22. (289) Fibromyalgia patients treated with pregabalin (lyrica) experience improved pain reduction regardless of baseline anxiety and depression levels
23. (287) Pregabalin (lyrica) treatment effects: Correlations of sleep diaries with Medical Outcomes Sleep Scale (MOS-SS) in fibromyalgia patients in two studies
24. (292) Treatment effects on changes in pain and changes in sleep: Pregabalin (lyrica) in fibromyalgia patients
25. (290) Pain changes in pregabalin-treated (lyrica) fibromyalgia patients associate with anxiety and depression changes
26. (704)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.